Citius Oncology (CTOR) EPS (Basic) (2023 - 2026)
Citius Oncology's (CTOR) quarterly EPS (Basic) came in at -$0.08 in Q2 2026, down 10.21% year-over-year from -$0.09 in Q2 2025, and up 68.91% quarter-over-quarter from -$0.27 in Q1 2026.
Powered by 
Analysis
Citius Oncology (CTOR) EPS (Basic) (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported EPS (Basic) for 4 consecutive years, with -$0.08 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 10.21% year-over-year to -$0.08 in Q2 2026; TTM through Jun 2026 was -$0.43, a 10.41% increase from a year earlier, with the FY2025 full-year figure at -$0.34, down 8.75% from the prior year.
- EPS (Basic) was -$0.08 for Q2 2026 at Citius Oncology, up from -$0.27 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.02 in Q1 2023 and troughed at -$2.15 in Q2 2024.
- A 4-year average of -$0.39 and a median of -$0.08 in 2026 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 12198.19% in 2024 and soared 96.52% in 2025, its largest moves.
- Over 4 years, EPS (Basic) stood at -$0.07 in 2023, then sank by 32.89% to -$0.09 in 2024, then soared by 32.01% to -$0.06 in 2025, then slumped by 30.72% to -$0.08 in 2026.
- The last three EPS (Basic) figures came in at -$0.08 (Q2 2026), -$0.27 (Q1 2026), and -$0.06 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -0.40 |
| 10 | Citius Oncology | 101.41 Mn | 101.41 Mn | 1.00 Mn | -0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Mar 31, 2026 | -0.27 |
| Dec 31, 2025 | -0.06 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -0.08 |
| Mar 31, 2025 | -0.11 |
| Dec 31, 2024 | -0.09 |
| Jun 30, 2024 | -2.15 |
| Mar 31, 2024 | -2.02 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.02 |